Short-term vs conventional glucocorticoid therapy in acute exacerbations of COPD

We are practicing short term of Steroid in management of asthma and COPD in ED, But this is very nice to hear from our colleagues to prove our practice. JAMA, in June 2013 published an article with concept of short term prednisone for 5 days is not inferior to 14 days of treatment in regards to 6 months reexacerbation in COPD patients, their conclusion is: “There was no significant difference in recovery of lung function and disease-related symptoms, but the shorter course resulted in a significantly reduced glucocorticoid exposure.

 

Link to Pubmed